Ensuring consistent chemical quality is paramount for industries manufacturing emulsion adhesives, especially those targeting the pharmaceutical sector. Dibutyl maleate, a staple intermediate, is frequently selected for its desirable plasticizing properties and integration compatibility. For emulsion adhesive formulations that may later interface with pharmaceutical synthesis, the need for rigorous purity specification becomes even more apparent—not just to meet regulatory demands, but to safeguard the integrity of complex downstream reactions.
The main pillars underpinning dibutyl maleate suitability for such demanding contexts include a stringent assay purity threshold (no less than 99.0%), meticulous monitoring and control of potentially reactive impurities, and uncompromising documentation for regulatory traceability. Each of these criteria directly correlates to both production efficiency and product stewardship in the wider industrial and pharmaceutical ecosystem.
Within fine chemical manufacturing, the discussion of purity is inseparably linked with operational risk, cost optimization, and regulatory assurance. Such companies must navigate a landscape of increasing quality and safety standards, ensuring that intermediates like dibutyl maleate are fit for both high-volume industrial adhesives and pharmaceutical synthesis. In this context, embracing robust purity specifications is not merely about compliance; it is a strategic choice that can determine both technical success and market access.
A key distinction exists between industrial and pharmaceutical purity standards, particularly as applied to a critical raw material such as dibutyl maleate, also known by its CAS number 105-76-0 and chemical formula C12H20O4, with a molecular weight of 228.29 g/mol. For industrial-grade material intended for emulsion adhesive formulations, the minimum acceptable assay is typically set at 99.0% or greater by gas chromatography (GC). This level reflects a balance between cost-effectiveness and reliable performance in non-pharmaceutical applications. However, when the same raw material will be involved downstream in pharmaceutical synthesis—where even trace contaminants can jeopardize regulatory acceptance and patient safety—the expectations increase substantially. Adhering to International Council for Harmonisation (ICH) guidelines such as Q3C (Residues of Solvents) and Q3D (Elemental Impurities) becomes non-negotiable, and rigorous additional controls on genotoxic impurities, mutagenic substances, and even isomeric composition are required.
Technical Insights operates as an ISO-certified supplier, recognizing the necessity for dual-track quality assurance. Our production and quality systems are designed to deliver dibutyl maleate that satisfies both industrial and regulatory-driven purity demands. More information, including product specifications and ordering options, is available on our product page.
Confirmation of assay purity exceeding 99.0% in bulk batches of dibutyl maleate is achieved through an array of validated analytical methods. The primary approach employs gas chromatography with a capillary column and flame ionization detector (GC-FID). This analysis rapidly pinpoints and quantifies the main compound and most low-level impurities, with sensitivity well below 0.1%. High-performance liquid chromatography (HPLC) offers complementary resolution for isomeric and related substances. Determination of water content, vital for resins and adhesives, is performed using Karl Fischer titration, which reliably detects even trace amounts of moisture. For inorganic impurities, especially elemental contaminants addressed under ICH Q3D, residue on ignition (ROI) is conducted, and if required, further profiled by inductively coupled plasma mass spectrometry (ICP-MS). Every batch is systematically reviewed through a comprehensive Certificate of Analysis (COA), which details compliance with requirements, including chemical identification, physical description, assay purity, water content, and residue on ignition, as well as storage and shelf life guidelines.
The typical specification profile for Technical Insights’ dibutyl maleate includes several key attributes. Chemically, the substance is identified as dibutyl (Z)-but-2-enedioate, referenced by CAS number 105-76-0. Its formula, C12H20O4, and molecular weight, 228.29 g/mol, are listed for traceability. Visual inspection confirms the product as a clear, colorless to pale yellow liquid. The assay by GC is never less than 99.0%. Water content, determined by Karl Fischer, does not exceed 0.1%. Residue on ignition is limited to below 0.01%. Heavy metals are quantified and limited below the thresholds set by ICH Q3D, commonly less than 10 ppm for Class 1 and Class 2 elements. The identification and purity of the sample are confirmed by both GC and infrared (IR) spectroscopy. Solutions demonstrate stability when stored in tightly closed containers at temperatures between 2°C and 8°C, away from light and moisture. Shelf life extends to 24 months under these conditions, barring any deviation from recommended storage practices. The product is packaged in inert-lined steel drums or fluorinated HDPE containers, adhering to global transport regulations for chemicals.
Water content and impurities play an outsized role in downstream synthesis, especially for processes that may feed into pharmaceutical active ingredient production. Elevated water content can catalyze unwanted hydrolysis of dibutyl maleate, producing maleic acid and butanol, both of which act as chain-termination agents or induce side reactions in polymerization or condensation steps. Isomeric and related organic impurities—such as dibutyl fumarate or partial esters—can compromise product yield, color stability, and even processing behavior of adhesives. In the pharmaceutical context, impurities that fall outside ICH Q3C Class 1–3 solvent limits or ICH Q3D elemental thresholds threaten not just yield, but also patient and regulatory safety. Technical Insights applies in-process controls throughout manufacturing, including online moisture monitoring and real-time GC impurity profiling, to ensure strict conformance with all declared specifications.
For buyers requiring bulk dibutyl maleate, assured purity and thorough documentation are essential. Technical Insights offers packaging from 25 liter HDPE carboys to 200 liter steel or UN-certified PE drums, each closed with tamper-evident seals and inert linings. Every consignment is provided with a Certificate of Analysis (COA) that itemizes results for each specification parameter, as well as a Safety Data Sheet (SDS) and Certificate of Origin (COO). As part of our ISO 9001 and ISO 14001 management system, every batch is tracked from raw materials through final inspection, with full traceability. Our quality assurance team conducts in-process testing at key intermediate stages, not just on final product, to assure proactive deviation management.
Above all, the pursuit of high-purity dibutyl maleate confers strategic advantages upon manufacturers of emulsion adhesives destined for pharmaceutical synthesis. By rigorously minimizing water and related impurities; verifying compliance through state-of-the-art analytical techniques such as GC-FID, HPLC, Karl Fischer titration, and ICP-MS; and thoroughly documenting every batch via COA, SDS, and COO, Technical Insights reinforces its position as a trusted supplier. Meeting—and exceeding—current ICH and USP requirements, we help our customers mitigate risk, enhance yield, and maintain full alignment with global standards for the industries of tomorrow.
Related Articles
